- Home
- TIXT vs APLT Comparison
TIXT vs APLT Comparison
Compare TIXT & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIXT
- APLT
- Stock Information
- Founded
- TIXT 2005
- APLT 2016
- Country
- TIXT Canada
- APLT United States
- Employees
- TIXT N/A
- APLT N/A
- Industry
- TIXT EDP Services
- APLT Biotechnology: Pharmaceutical Preparations
- Sector
- TIXT Technology
- APLT Health Care
- Exchange
- TIXT Nasdaq
- APLT Nasdaq
- Market Cap
- TIXT 812.7M
- APLT 52.9M
- IPO Year
- TIXT 2021
- APLT 2019
- Fundamental
- Price
- TIXT $3.73
- APLT $0.33
- Analyst Decision
- TIXT Hold
- APLT Buy
- Analyst Count
- TIXT 9
- APLT 7
- Target Price
- TIXT $4.17
- APLT $6.10
- AVG Volume (30 Days)
- TIXT 1.4M
- APLT 2.3M
- Earning Date
- TIXT 08-01-2025
- APLT 08-06-2025
- Dividend Yield
- TIXT N/A
- APLT N/A
- EPS Growth
- TIXT N/A
- APLT N/A
- EPS
- TIXT N/A
- APLT N/A
- Revenue
- TIXT $2,671,000,000.00
- APLT $265,000.00
- Revenue This Year
- TIXT $3.61
- APLT $1,768.13
- Revenue Next Year
- TIXT $3.59
- APLT $292.85
- P/E Ratio
- TIXT N/A
- APLT N/A
- Revenue Growth
- TIXT N/A
- APLT N/A
- 52 Week Low
- TIXT $2.13
- APLT $0.30
- 52 Week High
- TIXT $6.86
- APLT $10.62
- Technical
- Relative Strength Index (RSI)
- TIXT 69.96
- APLT 43.25
- Support Level
- TIXT $3.55
- APLT $0.30
- Resistance Level
- TIXT $3.76
- APLT $0.36
- Average True Range (ATR)
- TIXT 0.10
- APLT 0.03
- MACD
- TIXT -0.01
- APLT -0.00
- Stochastic Oscillator
- TIXT 85.71
- APLT 22.22
About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares
TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.